Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer chez ACOTEC SCIENTIFIC HOLDINGS LIMITED
Profil
Ulrich Reinhold Speck is the founder of InnoRa GmbH, which was founded in 2001.
He held the title of Managing Director & Legal Representative from 2001 to 2017.
Currently, he is the Chief Technology Officer at Acotec Scientific Holdings Ltd.
since 2021.
Previously, he worked as a Professor at Charité - Universitätsmedizin Berlin from 2000 to 2001.
Dr. Speck received his doctorate degree from Freie Universität Berlin in 1967.
Postes actifs de Ulrich Reinhold Speck
| Sociétés | Poste | Début |
|---|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 29/01/2021 |
Anciens postes connus de Ulrich Reinhold Speck
| Sociétés | Poste | Fin |
|---|---|---|
InnoRa GmbH
 InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 18/01/2017 |
| Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 01/01/2001 |
Formation de Ulrich Reinhold Speck
| Freie Universität Berlin | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |
